Work

Impacts of treatment lines and initiation timing of erlotinib for advanced non-small cell lung cancer.

Year: 2012

Type: article

Study design: Observational Study

Source: PubMed

Authors: Takuya Aoki, Satoshi Igawa, Naoki Furuya, Masato Katagiri, Junichirou Hisata, Sakurako Tajiri, Naoki Hayama, Masamichi Mineshita, Tetsuya Urano, Teruomi Miyazawa, Noriyuki Masuda, Tadashi Abe

Institution: Tokai University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2122499655

FWCI: 1.225

Cites: 38

Cited by: 7

Related to: 10